Hepion Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Hepion Pharmaceuticals, Inc.‘s stocks are currently a part of 16 hedge funds’ portfolios, which represents 3.12% of the total amount of its stocks outstanding. This makes up a total of 2.37M shares of Hepion Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -66.71% or -4.76M shares fewer. As for the holding position changes, 37.5% (6) of current hedge fund investors increased the number of shares held, 18.75% (3) of current holders sold a part of the shares held, and 18.75% (3) closed the holdings completely. 3 hedge funds are new holders of Hepion Pharmaceuticals, Inc. stock in Q1 2023, it is 18.75% of total holders.
Hedge funds holding Hepion Pharmaceuticals (Q3 2019 – Q1 2023)
| Q3 2019 | 4 |
|---|---|
| Q4 2019 | 11 |
| Q1 2020 | 6 |
| Q2 2020 | 5 |
| Q3 2020 | 12 |
| Q4 2020 | 28 |
| Q1 2021 | 38 |
| Q2 2021 | 44 |
| Q3 2021 | 37 |
| Q4 2021 | 39 |
| Q1 2022 | 33 |
| Q2 2022 | 27 |
| Q3 2022 | 24 |
| Q4 2022 | 27 |
| Q1 2023 | 16 |
Hedge funds changes in Hepion Pharmaceuticals positions (Q3 2019 – Q1 2023)
| Q3 2019 | 4 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2019 | 9 | 0 | 2 | 2 | -2 |
| Q1 2020 | 3 | 1 | 1 | 7 | -6 |
| Q2 2020 | 2 | 0 | 1 | 4 | -2 |
| Q3 2020 | 9 | 2 | 0 | 3 | -2 |
| Q4 2020 | 22 | 4 | 2 | 6 | -6 |
| Q1 2021 | 19 | 15 | 2 | 9 | -7 |
| Q2 2021 | 12 | 11 | 12 | 6 | 3 |
| Q3 2021 | 5 | 7 | 15 | 11 | -1 |
| Q4 2021 | 9 | 11 | 10 | 7 | 2 |
| Q1 2022 | 5 | 9 | 9 | 10 | 0 |
| Q2 2022 | 2 | 8 | 9 | 8 | 0 |
| Q3 2022 | 3 | 7 | 5 | 7 | 2 |
| Q4 2022 | 5 | 9 | 9 | 2 | 2 |
| Q1 2023 | 3 | 6 | 3 | 3 | 1 |
Hedge funds changes in Hepion Pharmaceuticals stock options (Q3 2019 – Q1 2023)
| Q3 2019 | 0 | 0 |
|---|---|---|
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 142,000 | 184,000 |
| Q4 2020 | 657,000 | 562,000 |
| Q1 2021 | 1,510,000 | 1,561,000 |
| Q2 2021 | 1,419,000 | 1,379,000 |
| Q3 2021 | 1,529,000 | 409,000 |
| Q4 2021 | 538,000 | 115,000 |
| Q1 2022 | 678,000 | 56,000 |
| Q2 2022 | 145,000 | 11,000 |
| Q3 2022 | 97,000 | 8,000 |
| Q4 2022 | 51,543 | 570 |
| Q1 2023 | 7,147,000 | 0 |